Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2010/01/01
-
Journal
-
Indian UGC (journal)
-
Refrences35
-
Citations32
-
Takashi Muraguchi
-
Akiyuki Kawawa
-
Shunichiro Kubota
Cite
Muraguchi, Takashi, et al. “Prohibitin Protects Against Hypoxia-Induced H9c2 Cardiomyocyte Cell Death”. Biomedical Research, vol. 31, no. 2, 2010, pp. 113-22, https://doi.org/10.2220/biomedres.31.113.
Muraguchi, T., Kawawa, A., & Kubota, S. (2010). Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death. Biomedical Research, 31(2), 113-122. https://doi.org/10.2220/biomedres.31.113
Muraguchi T, Kawawa A, Kubota S. Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death. Biomedical Research. 2010;31(2):113-22.
Journal Category
Medicine
Medicine (General)
You May Also Like
- Nitric oxide as a secretory product of mammalian cells
- The MAPK signaling cascade
- Vascular endothelial growth factor (VEGF) and its receptors
- Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
- An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Title | 2006 | |||
| Apoptosis of Rat Granulosa Cells after Staurosporine and Serum Withdrawal Is Suppressed by Adenovirus-Directed Overexpression of Prohibitin | 51 | 2007 | ||
Cellular oxygen sensing by mitochondria: old questions, new insight | Journal of Applied Physiology |
| 221 | 2000 |
| 10.1161/01.RES.75.3.426 | ||||
| Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations | Current Opinion in Pharmacology |
| 118 | 2008 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo | Journal of Experimental & Clinical Cancer Research |
| 1 | 2023 |
| Prohibitin inhibits high glucose‑induced apoptosis via maintaining mitochondrial function in human retinal capillary endothelial cells | Experimental and Therapeutic Medicine |
| 3 | 2022 |
| Phosphoproteomic response of cardiac endothelial cells to ischemia and ultrasound | Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics |
| 3 | 2021 |
Prohibitin‐1 Is a Dynamically Regulated Blood Protein With Cardioprotective Effects in Sepsis | Journal of the American Heart Association |
| 2021 | |
| Discovery of 3,3′-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands | European Journal of Medicinal Chemistry |
| 13 | 2020 |
Citations Analysis
The category
Medicine: Medicine (General) 12
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled The role and therapeutic potential of prohibitin in disease and was published in 2011. The most recent citation comes from a 2023 study titled Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo. This article reached its peak citation in 2012, with 6 citations. It has been cited in 28 different journals, 25% of which are open access. Among related journals, the Experimental and Therapeutic Medicine cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.